ABSTRACT
BACKGROUND: The performance of the galactomannan enzyme immunoassay (GM-EIA) is impaired in patients receiving mould-active antifungal therapy. The impact of mould-active antifungal therapy on Aspergillus PCR testing needs to be determined. OBJECTIVES: To determine the influence of anti-mould prophylaxis (AMP) on the performance of PCR blood testing to aid the diagnosis of proven/probable invasive aspergillosis (IA). METHODS: As part of the systematic review and meta-analysis of 22 cohort studies investigating Aspergillus PCR blood testing in 2912 patients at risk of IA, subgroup analysis was performed to determine the impact of AMP on the accuracy of Aspergillus PCR. The incidence of IA was calculated in patients receiving and not receiving AMP. The impact of two different positivity thresholds (requiring either a single PCR positive test result or ≥2 consecutive PCR positive test results) on accuracy was evaluated. Meta-analytical pooling of sensitivity and specificity was performed by logistic mixed-model regression. RESULTS: In total, 1661 (57%) patients received prophylaxis. The incidence of IA was 14.2%, significantly lower in the prophylaxis group (11%-12%) compared with the non-prophylaxis group (18%-19%) (Pâ<â0.001). The use of AMP did not affect sensitivity, but significantly decreased specificity [single PCR positive result threshold: 26% reduction (Pâ=â0.005); ≥2 consecutive PCR positive results threshold: 12% reduction (Pâ=â0.019)]. CONCLUSIONS: Contrary to its influence on GM-EIA, AMP significantly decreases Aspergillus PCR specificity, without affecting sensitivity, possibly as a consequence of AMP limiting the clinical progression of IA and/or leading to false-negative GM-EIA results, preventing the classification of probable IA using the EORTC/MSGERC definitions.
Subject(s)
Aspergillosis , Invasive Fungal Infections , Aspergillosis/diagnosis , Aspergillosis/prevention & control , Aspergillus/genetics , Humans , Mannans , Meta-Analysis as Topic , Polymerase Chain Reaction , Sensitivity and SpecificityABSTRACT
Interlaboratory evaluations of Mucorales qPCR assays were developed to assess the reproducibility and performance of methods currently used. The participants comprised 12 laboratories from French university hospitals (nine of them participating in the Modimucor study) and 11 laboratories participating in the Fungal PCR Initiative. For panel 1, three sera were each spiked with DNA from three different species (Rhizomucor pusillus, Lichtheimia corymbifera, Rhizopus oryzae). For panel 2, six sera with three concentrations of R. pusillus and L. corymbifera (1, 10, and 100 genomes/ml) were prepared. Each panel included a blind negative-control serum. A form was distributed with each panel to collect results and required technical information, including DNA extraction method, sample volume used, DNA elution volume, qPCR method, qPCR template input volume, qPCR total reaction volume, qPCR platform, and qPCR reagents used. For panel 1, assessing 18 different protocols, qualitative results (positive or negative) were correct in 97% of cases (70/72). A very low interlaboratory variability in Cq values (SD = 1.89 cycles) were observed. For panel 2 assessing 26 different protocols, the detection rates were high (77-100%) for 5/6 of spiked serum. There was a significant association between the qPCR platform and performance. However, certain technical steps and optimal combinations of factors may also impact performance. The good reproducibility and performance demonstrated in this study support the use of Mucorales qPCR as part of the diagnostic strategy for mucormycosis.
Subject(s)
Clinical Laboratory Techniques/standards , DNA, Fungal/genetics , Molecular Diagnostic Techniques/standards , Mucorales/genetics , Mucormycosis/blood , Mucormycosis/diagnosis , Real-Time Polymerase Chain Reaction/standards , Clinical Laboratory Techniques/instrumentation , Clinical Laboratory Techniques/methods , France , Hospitals, University/statistics & numerical data , Humans , Observer Variation , Reproducibility of ResultsABSTRACT
Background/Objectives: Azole resistance in Aspergillus fumigatus associated with the TR34/L98H mutations in the cyp51A gene have been increasingly reported. Determining the environmental resistance rate has been deemed important when considering front-line therapy for invasive aspergillosis. The aim of the study was to determine prevalence of azole resistance in environmental A. fumigatus isolates across South Wales. Methods: Over 5 months in 2015, 513 A. fumigatus isolates were cultured from 671 soil and 44 air samples and were screened for azole resistance using VIPcheck™ agar plates containing itraconazole, voriconazole and posaconazole. Resistance was confirmed by the CLSI M38-A2 methodology. The mechanism of resistance was investigated using the PathoNostics AsperGenius® Assay. Results: Screening by VIPcheck™ plate identified azole-resistance in 30 isolates, most of which (28/30) harbored the TR34/L98H mutation, generating a prevalence of 6.0%. Twenty-five isolates had a MIC of ≥2 mg/L with itraconazole, 23 isolates had a MIC of ≥2 mg/L with voriconazole and seven isolates had a MIC ≥0.25 mg/L with posaconazole. All isolates deemed resistant by VIPcheck™ plates were resistant to at least one azole by reference methodology. Conclusions: There is significant environmental azole resistance (6%) in South Wales, in close proximity to patients susceptible to aspergillosis. Given this environmental reservoir, azole resistance should be routinely screened for in clinical practice and environmental monitoring continued.
ABSTRACT
The galactomannan enzyme immunoassay (GM-EIA) is widely utilized for the diagnosis of invasive aspergillosis (IA). There is inconsistent reproducibility of results between centers when the assay is processed manually. Automation of EIAs can reduce variation. This study investigated the semiautomation of the GM-EIA on the DS2 (Dynex) platform in the following three stages: (i) DS2 GM-EIA method validation with experimental samples, (ii) DS2 retesting of case-defined clinical samples, and (iii) a 12-month audit of DS2 GM-EIA performance. In stage i, Bland-Altman analysis demonstrated a reduced variance between optical density index (ODI) values for samples processed on two DS2 platforms (mean difference, -0.02; limits of agreement [LOA], -0.19 to 0.14) compared with the variance between samples processed manually and on a DS2 platform (mean difference, 0.02; LOA, -0.25 to 0.3). In stage ii, 100% (14/14 samples) qualitative agreement was observed for serum samples from patients with IA, with no significant change in the ODI values when samples were processed on the DS2 platform. A significant decrease in ODI values was observed for control serum samples on the DS2 platform (difference, 0.01; P = 0.042). In stage iii, a significant reduction in the frequency of equivocal results, from 5.56% (136/2,443 samples) to 1.56% (15/961 samples), was observed after DS2 automation (difference, 4.0%; 95% confidence interval [CI], 2.7 to 5.2%; P < 0.01), with an equivalent increase in negative results. This study demonstrates that GM-EIA automation may reduce intersite variability. Automation does not have an impact on the repeatability of truly positive results but contributes to a reduction in false-positive (equivocal) GM-EIA results, reducing the need to retest a significant proportion of samples.
Subject(s)
Antigens, Fungal/blood , Aspergillus/immunology , Automation, Laboratory/methods , Diagnostic Tests, Routine/standards , Immunoenzyme Techniques/standards , Invasive Pulmonary Aspergillosis/diagnosis , Mannans/blood , Diagnostic Tests, Routine/methods , Galactose/analogs & derivatives , Humans , Immunoenzyme Techniques/methods , Reference Standards , Reproducibility of ResultsABSTRACT
We investigated an outbreak of 396 Salmonella enterica serotype I 4,5,12:i:- infections to determine the source. After 7 weeks of extensive hypothesis-generation interviews, no refined hypothesis was formed. Nevertheless, a case-control study was initiated. Subsequently, an iterative hypothesis-generation approach used by a single interviewing team identified brand A not-ready-to-eat frozen pot pies as a likely vehicle. The case-control study, modified to assess this new hypothesis, along with product testing indicated that the turkey variety of pot pies was responsible. Review of product labels identified inconsistent language regarding preparation, and the cooking instructions included undefined microwave wattage categories. Surveys found that most patients did not follow the product's cooking instructions and did not know their oven's wattage. The manufacturer voluntarily recalled pot pies and improved the product's cooking instructions. This investigation highlights the value of careful hypothesis-generation and the risks posed by frozen not-ready-to-eat microwavable foods.
Subject(s)
Cooking , Disease Outbreaks , Food Labeling , Salmonella Food Poisoning/epidemiology , Salmonella enterica , Adolescent , Adult , Aged , Aged, 80 and over , Case-Control Studies , Child , Child, Preschool , Data Collection , Female , Food Safety , Frozen Foods , Humans , Infant , Male , Middle Aged , Public Health/methods , United States/epidemiology , Young AdultABSTRACT
In late October 2007, an outbreak of multidrug-resistant Salmonella Newport infections affected 42 case patients in California, Arizona, Idaho, and Nevada. A case-control study implicated ground beef from one chain store. Despite detailed ground beef purchase histories--including shopper card information for several case patients--traceback efforts by both the U.S. Department of Agriculture, Food Safety and Inspection Service and the California Department of Public Health were unable to identify the source of contamination. Case patients consumed multiple types of ground beef products purchased at numerous chain store A retail locations. These stores had received beef products for grinding from multiple beef slaughter-processing establishments. Detailed retail grinding logs and grinding policies that prevent cross-contamination between batches of ground beef products are crucial in the identification of contaminated beef products associated with foodborne illness.
Subject(s)
Drug Resistance, Multiple, Bacterial , Food Contamination/analysis , Meat Products/microbiology , Salmonella Food Poisoning/epidemiology , Salmonella/drug effects , Animals , Arizona , California , Cattle , Disease Outbreaks , Food Microbiology , Humans , Idaho , Nevada , Salmonella Food Poisoning/microbiologyABSTRACT
AIMS: To investigate the impact of routine use of biomarkers for diagnosing fungal infection within a care pathway on antifungal usage and clinical outcomes. METHODS: A cohort of high-risk haematology and stem cell transplant patients was entered into a neutropenic care pathway in which targeted diagnostic testing replaced empiric antifungal treatment. Patients were screened twice a week by PCR and antigen testing during fever or when chronic graft versus host disease was present and were followed-up for a minimum of 1 year. RESULTS: No excess morbidity or mortality was seen in patients in whom empiric antifungal treatment was withheld, and there were substantial savings in antifungal drug expenditure. CONCLUSIONS: The introduction of a comprehensive diagnostic surveillance strategy to exclude invasive fungal infection in high-risk patients with haematological malignancy and those undergoing transplantation can result in improvements in clinical management. There are also potential additional benefits of improved patient survival, decreased morbidity and decreased hospital stay.
Subject(s)
Hematologic Neoplasms/complications , Mycoses/diagnosis , Opportunistic Infections/diagnosis , Stem Cell Transplantation/adverse effects , Adolescent , Adult , Aged , Aged, 80 and over , Antifungal Agents/administration & dosage , Aspergillosis/complications , Aspergillosis/diagnosis , Aspergillosis/immunology , Biomarkers/analysis , Candidiasis/complications , Candidiasis/diagnosis , Candidiasis/immunology , Critical Pathways , Epidemiologic Methods , Female , Humans , Immunocompromised Host , Male , Middle Aged , Mycoses/complications , Mycoses/immunology , Opportunistic Infections/complications , Opportunistic Infections/immunology , Polymerase Chain Reaction , Young AdultABSTRACT
There are conflicting reports on the agreement between the Clinical and Laboratory Standards Institute disk diffusion (M44-A) and reference broth microdilution (M27-A) methods for determination of antifungal susceptibility of yeasts. The antifungal susceptibility of 541 yeasts, the majority of which were from the oral cavity, was determined using these two methods and the accuracy of the disk diffusion method assessed for clinical testing of various Candida species. Of the strains tested, Candida albicans predominated (390 out of 541). The classification of susceptibility determined by the disk diffusion method was largely in concordance with that obtained using the broth dilution method, regardless of species within Candida genus. The overall observed agreement between these two methods was 94.7% for fluconazole and 96.7% for voriconazole was with a 'very major' discrepancy level of 1.5% and 1.7% respectively. This study demonstrates a strong agreement of the simple disk diffusion method with the more labour intensive 'gold standard' broth microdilution method. These findings would support the use of the disk diffusion method in a routine mycology service.
Subject(s)
Antifungal Agents/pharmacology , Candida/drug effects , Fluconazole/pharmacology , Microbiological Techniques/methods , Pyrimidines/pharmacology , Triazoles/pharmacology , Disk Diffusion Antimicrobial Tests , Humans , Microbial Sensitivity Tests , Reproducibility of Results , VoriconazoleABSTRACT
Active surveillance for laboratory-confirmed Salmonella serotype Enteritidis (SE) infection revealed a decline in incidence in the 1990s, followed by an increase starting in 2000. We sought to determine if the fluctuation in SE incidence could be explained by changes in foodborne sources of infection. We conducted a population-based case-control study of sporadic SE infection in five of the Foodborne Diseases Active Surveillance Network (FoodNet) sites during a 12-month period in 2002-2003. A total of 218 cases and 742 controls were enrolled. Sixty-seven (31%) of the 218 case-patients and six (1%) of the 742 controls reported travel outside the United States during the 5 days before the case's illness onset (OR 53, 95% CI 23-125). Eighty-one percent of cases with SE phage type 4 travelled internationally. Among persons who did not travel internationally, eating chicken prepared outside the home and undercooked eggs inside the home were associated with SE infections. Contact with birds and reptiles was also associated with SE infections. This study supports the findings of previous case-control studies and identifies risk factors associated with specific phage types and molecular subtypes.
Subject(s)
Population Surveillance/methods , Salmonella Food Poisoning/epidemiology , Salmonella enteritidis , Adolescent , Adult , Aged , Aged, 80 and over , Animals , Case-Control Studies , Chickens/microbiology , Child , Child, Preschool , Eggs/microbiology , Food Microbiology , Humans , Incidence , Infant , Middle Aged , Risk Factors , Salmonella Food Poisoning/microbiology , Salmonella enteritidis/classification , Salmonella enteritidis/genetics , Salmonella enteritidis/isolation & purification , Salmonella enteritidis/pathogenicity , Travel , United States/epidemiologyABSTRACT
Endocarditis secondary to Aspergillus niger has not been described in a leukaemic patient. We describe a case of A. niger endocarditis in a patient with acute myeloid leukaemia and refractory fever. The microbiological cause of his endocarditis was initially misdiagnosed because he fulfilled the Duke criteria for enterococcal endocarditis. A polymerase chain reaction test utilizing pan-fungal primers detected a product from an Aspergillus sp. The DNA was subsequently sequenced and was found to have 100% homology with A. niger. A postmortem revealed fungal endocarditis secondary to disseminated aspergillosis, without evidence of bacterial endocarditis. The patient was found to have a lung aspergilloma that was possibly occupationally acquired, and may have been long standing.
Subject(s)
Aspergillosis/diagnosis , Aspergillus niger/isolation & purification , Endocarditis/diagnosis , Endocarditis/microbiology , Leukemia, Myeloid, Acute/complications , Polymerase Chain Reaction/methods , Aspergillosis/microbiology , DNA, Fungal/analysis , Fatal Outcome , Humans , Male , Middle AgedABSTRACT
The United States Department of Agriculture (USDA) Food Safety Inspection Service (FSIS) adopted Hazard Analysis and Critical Control Point Systems and established finished product standards for Salmonella in slaughter plants to improve food safety for meat and poultry. In order to make significant improvements in food safety, measures must be taken at all points in the farm-to-table chain including production, transportation, slaughter, processing, storage, retail, and food preparation. Since pathogens can be introduced or multiplied anywhere along the continuum, success depends on consideration and comparison of intervention measures throughout the continuum. Food animal and public health veterinarians can create the necessary preventative environment that mitigates risks for food borne pathogen contamination.
Subject(s)
Food Contamination/prevention & control , Food Microbiology , Meat Products/standards , Poultry Products/standards , Animals , Cattle , Chickens , Escherichia coli , Meat Products/microbiology , Meat-Packing Industry/standards , Poultry Products/microbiology , Public Health , Salmonella , Sanitation , Swine , TurkeysABSTRACT
Foodborne illness is a major public health concern. The largest number of foodborne illness cases attributed to poultry and poultry products are caused by paratyphoid serotypes of Salmonella and by Campylobacter jejuni. The effective prevention of foodborne disease requires an understanding that contamination can be introduced into foods at numerous points along the food chain. Since multiple entry points exist for foodborne pathogens, multifaceted intervention approaches are required to successfully control contamination of poultry during the various phases of the growth period and processing procedure of broiler chickens. Strategies during the grow-out period (the period during which day-old chicks are raised to six- to seven-week-old broiler chickens) include sanitation, biosecurity, vaccine and drug therapy, and biological control procedures, such as those aimed at preventing colonisation. There are also many critical control points identified in the processing plant which reduce contamination. These include temperature controls (washer and product), chemical interventions, water replacements and counter-flow technology in the scalder and chiller, and equipment maintenance. Transportation and food handling at retail outlets and by the consumer (i.e., storage at the proper temperature and adequate cooking) are the final critical control points in the farm-to-table continuum. It is important to apply risk reduction strategies throughout the food chain. These include: easing the development and implementation of voluntary animal production 'best management practices', implementing in-plant hazard analysis and critical control point systems, developing effective transportation and refrigeration standards, working to facilitate adoption of the model Food Code in all States and providing educational materials and support for public health activities nationwide.
Subject(s)
Campylobacter Infections/prevention & control , Campylobacter jejuni , Food Microbiology , Meat/standards , Poultry Products/standards , Salmonella Food Poisoning/prevention & control , Animals , Campylobacter Infections/epidemiology , Chickens/microbiology , Disease Outbreaks , Food Handling/standards , Humans , Meat/microbiology , Poultry Products/microbiology , Salmonella Food Poisoning/epidemiology , United States/epidemiologyABSTRACT
Previous attempts to induce mucosal antibodies in rhesus monkeys by enteric immunization have resulted in only modest and short-lived responses, dominated by immunoglobulin M (IgM) antibodies in the plasma. In this study, two groups of rhesus monkeys were immunized intranasally three times at 2-week intervals with a bacterial protein antigen (AgI/II) either chemically coupled to or mixed with the B subunit of cholera toxin (CT), a known potent mucosal immunogen and carrier for other immunogens. Cells secreting antibodies, predominantly of the IgA isotype, to AgI/II and to CT were detected in the peripheral blood 1 week after each immunization, indicating the dissemination of IgA-secreting precursor cells through the mucosal immune system. IgG and, to a lesser extent, IgA antibodies to both proteins were induced in the plasma commencing after the second immunization. Plasma IgE concentrations and IgE antibody levels were not consistently raised during the immunization period. IgA antibodies were found in nasal and vaginal washes. Nasal IgG but not IgA antibodies showed a significant positive correlation with plasma IgG antibody levels, suggesting that they were largely derived by transudation from the circulation. Analysis of the molecular form of vaginal IgA indicated that both secretory and monomeric forms of IgA were present in various proportions. Furthermore, neither IgG nor IgA antibodies in vaginal washes were correlated with plasma antibody responses, suggesting the contribution of locally synthesized antibodies of both isotypes. Comparison of the responses between the two groups of animals showed only sporadic significant differences, indicating that intranasal immunization with AgI/II either coupled to or mixed with the B subunit of CT was equally effective at inducing generalized IgA antibody responses in the mucosal immune system and predominantly IgG antibodies in the plasma.
Subject(s)
Antibodies, Bacterial/biosynthesis , Antigens, Bacterial/immunology , Bacterial Proteins/immunology , Cholera Toxin/immunology , Nasal Mucosa/immunology , Saliva/immunology , Streptococcus mutans/immunology , Vagina/immunology , Administration, Intranasal , Animals , Female , Immunization , Immunoglobulin A, Secretory/biosynthesis , Intestines/immunology , Macaca mulattaSubject(s)
Immunoglobulin A/biosynthesis , Immunoglobulin A/metabolism , Liver/immunology , Animals , Antibodies, Bacterial/biosynthesis , Antibodies, Bacterial/metabolism , Antigens, Bacterial , Biological Transport, Active , Biopolymers/metabolism , Cytokines/physiology , Immunity, Mucosal , Immunization , Kinetics , Liver/cytology , Mice , Mice, Inbred BALB C , Receptors, Polymeric Immunoglobulin/metabolism , Streptococcus mutans/immunology , T-Lymphocytes/immunologySubject(s)
Antigens, Bacterial/administration & dosage , Immunoglobulin A, Secretory/biosynthesis , Saliva/immunology , Streptococcus mutans/immunology , Administration, Intranasal , Animals , Bacterial Proteins/immunology , Dental Caries/prevention & control , Immunity, Mucosal , Immunization , Rats , Rats, Inbred F344 , Streptococcal Infections/prevention & control , Streptococcus mutans/pathogenicity , Virulence/immunologyABSTRACT
Establishing an exclusive minimally invasive surgery suite requires a commitment from management, administration, staff, and physicians. A specialized, dedicated staff becomes devoted to perfecting the procedures. There are many rewards associated with this obligation, the most rewarding being improvement in total quality patient care.
Subject(s)
Laparoscopy , Laser Therapy , Operating Rooms/organization & administration , Hospital Design and Construction , Humans , Quality of Health CareABSTRACT
Sera from patients with subacute bacterial endocarditis (SBE) due to Streptococcus mutans or other oral streptococci and from normal subjects were assayed by enzyme-linked immunosorbent assay for antibodies to defined S. mutans antigens. Antibodies of IgG and IgA isotypes to Ag I/II and Ag III were greatly elevated in S. mutans-SBE sera, and the IgA antibodies in 3 sera included both polymeric and monomeric forms. Elevated IgM and IgG anti-lipoteichoic acid and IgG and IgA anti-serotype c polysaccharide antibodies were also found. The sera of 4 of 6 patients infected with other oral streptococci also displayed antibodies to S. mutans Ag I/II. Sera of 3 patients infected with Streptococcus mitis or Streptococcus oralis, but none of the S. mutans-infected cases, showed elevated antibodies to human heart sarcolemma, and all SBE sera had elevated rheumatoid factor. These results suggest that the known surface protein antigens of S. mutans are immunodominant in humans, and are not likely to be heart cross-reactive.
Subject(s)
Antibodies, Bacterial/blood , Antigens, Bacterial/immunology , Endocarditis, Subacute Bacterial/immunology , Streptococcal Infections/immunology , Streptococcus mutans/immunology , Antigens, Surface/immunology , Cross Reactions , Endocarditis, Subacute Bacterial/microbiology , Humans , Immunoglobulin A/blood , Immunoglobulin G/blood , Immunoglobulin M/blood , Lipopolysaccharides/immunology , Rheumatoid Factor/blood , Sarcolemma/immunology , Streptococcus/immunology , Streptococcus sanguis/immunology , Teichoic Acids/immunologySubject(s)
Antigens, Bacterial/immunology , Bacterial Proteins/immunology , Cholera Toxin/immunology , Immunotoxins/administration & dosage , Peptides/immunology , Vaccines, Synthetic/administration & dosage , Administration, Oral , Animals , Antigens, Bacterial/administration & dosage , Bacterial Proteins/administration & dosage , Cholera Toxin/administration & dosage , Humans , Peptides/administration & dosage , Vaccines, Synthetic/immunologyABSTRACT
Polymeric and metal oxide planar waveguides were used to demonstrate the potential of a miniature spectrometer. Multiwavelength light was transmitted through the substrate and coupled into the waveguide through a diffraction grating located at the substrate/waveguide interface. A second diffraction grating spatially dispersed the light propagated through the waveguide into component wavelengths for rapid analysis with a photodiode array detector. These results suggest that planar waveguides can be used to perform attenuated total internal reflection measurements in the visible and near-IR regions for chemical analysis of weak vibrational overtones and combination modes with effective path lengths of several millimeters.